Biome Grow Delivers on Massive Cannabis Supply Contract


Ryan Allway

February 13th, 2019

Exclusive, News, Top Story


Canada’s cannabis industry continues to face supply shortages following adult-use legalization last year. While new licensed producers are coming online every week and established companies are ramping up production, many experts believe that the supply shortage will persist for at least another year or two. These dynamics have created an opportunity for existing producers to increase revenue and market share.

Biome Grow Inc.(CSE: BIO) (OTCQB: BIOIF) (FFT: 6OTA) recently began its first shipments to Newfoundland and Labrador under a contract that is projected to generate about $100 million in annual revenue by 2020. Investors may want to take a closer look at the stock given these developments and its near-term path towards commercialization.

Click here to receive an investor presentation and corporate updates

Cannabis Supply Shortage

Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis. With the massive demand for product, many private and government-owned retailers have experienced troublemaintaining adequate supply. Quebec’s retailers operate only three days per week and New Brunswick’s provincial retailer laid off 60 workers due to a lack of supply.

These problems could worsen when Ontario opens its first 25 brick-and-mortar stores at the beginning of April. Six months later, the legalization of edibles could further influence the supply and demand dynamic. There’s evidence that edibles will become even more popular than flower across Canada. After all, edibles surpassed flower demand in the United States back in 2017 and licensed producers will likely be drawn to the higher margin potential.

Health Canada continues to approve new licensed producers, but many of these businesses require months to get to an operational state. Some industry experts believe that the supply shortage could last years, while others believe that the supply shortage could be resolved very soon thanks existing licensed producers ramping up production. Either way, the industry continues to see a healthy amount of demand from consumers.

Click here to receive an investor presentation and corporate updates

Biome Begins Shipments

 Biome Grow recently announced  the first shipments of finished product to Newfoundland and Labrador, which have both experienced significant supply shortages in recent months. The company’s Back Home Medical Cannabis Corporation, a wholly-owned subsidiary, signed a deal with Newfoundland and Labrador in November 2018, which was the largest supply agreement in Atlantic Canada and one of the top five nationwide by volume.

Later this month, the company plans to send a second shipment of finished products with a focus on independent retail locations. Management began investing $500,000 over five years for research and development in the province, adding that the investment in the provincial ecosystem supports its commitment to the supply chain. The supply agreement is projected to gross about $100 million per year beginning next year.

Biome Grow is also finalizing the site selection for five wholly-owned retail locations in the province, which are expected to open by this Spring. By capturing value across the entire supply chain, the company could generate more revenue at higher margins than it would be selling products wholesale to other retail outlets. The company could also improve brand loyalty by promoting its own products over competitors.

Click here to receive an investor presentation and corporate updates

Looking Ahead

Biome Grow Inc. (CSE: BIO) (OTCQB: BIOIF) (FFT: 6OTA) is well positioned to capitalize on Canada’s cannabis supply shortage through its massive supply contract with Newfoundland and Labrador. With initial shipments underway, the company is starting to generate meaningful revenue as it works towards a roughly $100 million annual run rate over the next few years.

For more information, visit the company’s website at www.biomegrow.com

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading